Stock AFMD AFFIMED N.V.
Add to a list
To use this feature you must be a member
Log inSign up

News Affimed N.V.

Equities

AFMD

NL0015001ZQ0

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
5.35 USD +7.00% Intraday chart for Affimed N.V. +2.29% -14.40%
Apr. 01 Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating MT
Apr. 01 HC Wainwright Adjusts Affimed's Price Target to $10 From $50, Maintains Buy Rating MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wells Fargo Cuts Affimed Price Target to $25 From $30, Maintains Overweight Rating
MT
HC Wainwright Adjusts Affimed's Price Target to $10 From $50, Maintains Buy Rating
MT
Affimed N.V. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Affimed N.V., 2023 Earnings Call, Mar 28, 2024
Affimed Reports 2023 Financial Results and Operational Progress
AQ
Affimed N.V. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Affimed To Report Full Year 2023 Financial Results & Corporate Update on March 28, 2024
AQ
Affimed N : Form 6-K
PU
Affimed Announces 1-for-10 Reverse Stock Split
AQ
AFFIMED ANNOUNCES LEADERSHIP CHANGE AND ORGANIZATIONAL RESTRUCTURING
AQ
Affimed Provides Clinical Response Update on AFM24-102 Trial in EGFR-wildtype Non-Small Cell Lung Cancer
GL
Affimed N.V. Provides Clinical Response Update on AFM24-102 Trial in EGFR-Wildtype Non-Small Cell Lung Cancer
CI
Affimed Announces Leadership Change and Organizational Restructuring
AQ
Affimed N.V. Announces CEO Changes
CI
Affimed N.V. Announces Management Changes
CI
Sector Update: Health Care Stocks Mixed Late Afternoon
MT
Sector Update: Health Care Stocks Gain in Afternoon Trading
MT
Affimed to Sell AbCheck to Ampersand Biomedicines for $6 Million in Cash, Stock; Shares Fall
MT
Affimed Announces Sale of Wholly-Owned Subsidiary AbCheck
AQ
Ampersand Biomedicines Inc. entered into a definitive agreement to acquire AbCheck s.r.o. from Affimed N.V. for $6.4 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AFMD Stock
  4. News Affimed N.V.